Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Association between variants in inflammation and cancer-associated genes and risk and survival of cholangiocarcinoma.

Chaiteerakij R, Juran BD, Aboelsoud MM, Harmsen WS, Moser CD, Giama NH, Allotey LK, Mettler TA, Baichoo E, Zhang X, Therneau TM, Lazaridis KN, Roberts LR.

Cancer Med. 2015 Oct;4(10):1599-602. doi: 10.1002/cam4.501. Epub 2015 Aug 15.

2.

Continuation of metformin use after a diagnosis of cirrhosis significantly improves survival of patients with diabetes.

Zhang X, Harmsen WS, Mettler TA, Kim WR, Roberts RO, Therneau TM, Roberts LR, Chaiteerakij R.

Hepatology. 2014 Dec;60(6):2008-16. doi: 10.1002/hep.27199. Epub 2014 Jul 31.

3.

Efficacy and safety of transarterial radioembolization versus chemoembolization in patients with hepatocellular carcinoma.

Moreno-Luna LE, Yang JD, Sanchez W, Paz-Fumagalli R, Harnois DM, Mettler TA, Gansen DN, de Groen PC, Lazaridis KN, Narayanan Menon KV, Larusso NF, Alberts SR, Gores GJ, Fleming CJ, Slettedahl SW, Harmsen WS, Therneau TM, Wiseman GA, Andrews JC, Roberts LR.

Cardiovasc Intervent Radiol. 2013 Jun;36(3):714-23. doi: 10.1007/s00270-012-0481-2. Epub 2012 Oct 24.

4.

Risk factors for intrahepatic cholangiocarcinoma: association between metformin use and reduced cancer risk.

Chaiteerakij R, Yang JD, Harmsen WS, Slettedahl SW, Mettler TA, Fredericksen ZS, Kim WR, Gores GJ, Roberts RO, Olson JE, Therneau TM, Roberts LR.

Hepatology. 2013 Feb;57(2):648-55. doi: 10.1002/hep.26092. Epub 2012 Dec 12.

5.

Viral hepatitis among Somali immigrants in Minnesota: association of hepatitis C with hepatocellular carcinoma.

Shire AM, Sandhu DS, Kaiya JK, Oseini AM, Yang JD, Chaiteerakij R, Mettler TA, Giama NH, Roberts RO, Therneau TM, Petersen GM, Knutson KL, Roberts LR.

Mayo Clin Proc. 2012 Jan;87(1):17-24. doi: 10.1016/j.mayocp.2011.08.001.

6.

Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma.

Oseini AM, Chaiteerakij R, Shire AM, Ghazale A, Kaiya J, Moser CD, Aderca I, Mettler TA, Therneau TM, Zhang L, Takahashi N, Chari ST, Roberts LR.

Hepatology. 2011 Sep 2;54(3):940-8. doi: 10.1002/hep.24487. Epub 2011 Aug 8.

7.

Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma.

Yang JD, Kim WR, Coelho R, Mettler TA, Benson JT, Sanderson SO, Therneau TM, Kim B, Roberts LR.

Clin Gastroenterol Hepatol. 2011 Jan;9(1):64-70. doi: 10.1016/j.cgh.2010.08.019. Epub 2010 Sep 8.

8.

Liver transplantation after radioembolization in a patient with unresectable HCC.

Luna LE, Kwo PY, Roberts LR, Mettler TA, Gansen DN, Andrews JC, Wiseman GA, Misra VL.

Nat Rev Gastroenterol Hepatol. 2009 Nov;6(11):679-83. doi: 10.1038/nrgastro.2009.165. Review.

9.

The JNK inhibitor SP600129 enhances apoptosis of HCC cells induced by the tumor suppressor WWOX.

Aderca I, Moser CD, Veerasamy M, Bani-Hani AH, Bonilla-Guerrero R, Ahmed K, Shire A, Cazanave SC, Montoya DP, Mettler TA, Burgart LJ, Nagorney DM, Thibodeau SN, Cunningham JM, Lai JP, Roberts LR.

J Hepatol. 2008 Sep;49(3):373-83. doi: 10.1016/j.jhep.2008.05.015. Epub 2008 Jun 9.

10.

Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival.

Jiang J, Gusev Y, Aderca I, Mettler TA, Nagorney DM, Brackett DJ, Roberts LR, Schmittgen TD.

Clin Cancer Res. 2008 Jan 15;14(2):419-27. doi: 10.1158/1078-0432.CCR-07-0523.

11.

The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population.

Leerapun A, Suravarapu SV, Bida JP, Clark RJ, Sanders EL, Mettler TA, Stadheim LM, Aderca I, Moser CD, Nagorney DM, LaRusso NF, de Groen PC, Menon KV, Lazaridis KN, Gores GJ, Charlton MR, Roberts RO, Therneau TM, Katzmann JA, Roberts LR.

Clin Gastroenterol Hepatol. 2007 Mar;5(3):394-402; quiz 267.

12.

Hypothyroidism: a possible risk factor for liver cancer in patients with no known underlying cause of liver disease.

Reddy A, Dash C, Leerapun A, Mettler TA, Stadheim LM, Lazaridis KN, Roberts RO, Roberts LR.

Clin Gastroenterol Hepatol. 2007 Jan;5(1):118-23. Epub 2006 Sep 26.

PMID:
17008133
13.

A patient orientation program at a comprehensive cancer center.

Deshler AM, Fee-Schroeder KC, Dowdy JL, Mettler TA, Novotny P, Zhao X, Frost MH.

Oncol Nurs Forum. 2006 May 3;33(3):569-78.

PMID:
16676013
14.

MYH Y165C and G382D mutations in hepatocellular carcinoma and cholangiocarcinoma patients.

Baudhuin LM, Roberts LR, Enders FT, Swanson RL, Mettler TA, Aderca I, Stadheim LM, Highsmith WE.

J Cancer Res Clin Oncol. 2006 Mar;132(3):159-62. Epub 2005 Nov 15.

PMID:
16292541

Supplemental Content

Loading ...
Support Center